Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 8 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Cocrystal Pharma, Inc. | 657,161 | reported | 15 Mar 2016 | tx 8+18,407,161 |
| Intec Pharma Ltd. | 300,000 | reported | 15 Jul 2020 | tx 4+545,000 |
| QLT INC/BC | 50,000 | reported | 17 Jun 2016 | tx 22+447,400−37,000 |
| Travere Therapeutics, Inc. | 12,000 | reported | 19 May 2026 | tx 35+355,000−56,000 |
| Indaptus Therapeutics, Inc. | 3,033 | reported | 11 Feb 2026 | tx 32+1,429,393−30,314 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 19 May 2026 | GRANT_AWARD | Travere Therapeutics, Inc. | 4,000 | 0.00 USD | |
| 19 May 2026 | GRANT_AWARD | Travere Therapeutics, Inc. | 12,000 | 0.00 USD | deriv |
| 04 May 2026 | EXERCISE | Travere Therapeutics, Inc. | 8,000 | 16.33 USD | 10b5-1 |
| 04 May 2026 | SALE | Travere Therapeutics, Inc. | 8,000 | 45.00 USD | 10b5-1 |
| 04 May 2026 | EXERCISE | Travere Therapeutics, Inc. | 8,000 | 0.00 USD | 10b5-1deriv |
| 11 Feb 2026 | OTHER | Indaptus Therapeutics, Inc. | 3,033 | — | deriv |
| 11 Feb 2026 | GRANT_AWARD | Indaptus Therapeutics, Inc. | 3,033 | — | deriv |
| 11 Feb 2026 | OTHER | Indaptus Therapeutics, Inc. | 1,519 | — | deriv |
| 11 Feb 2026 | GRANT_AWARD | Indaptus Therapeutics, Inc. | 1,519 | — | deriv |
| 11 Feb 2026 | OTHER | Indaptus Therapeutics, Inc. | 12,136 | — | deriv |
| 11 Feb 2026 | GRANT_AWARD | Indaptus Therapeutics, Inc. | 12,136 | — | deriv |
| 22 Dec 2025 | GRANT_AWARD | Indaptus Therapeutics, Inc. | 216,617 | 2.03 USD | |
| 27 Jul 2025 | GRANT_AWARD | Indaptus Therapeutics, Inc. | 6,068 | 8.30 USD | |
| 27 Jul 2025 | GRANT_AWARD | Indaptus Therapeutics, Inc. | 12,136 | 8.30 USD | deriv |
| 15 May 2025 | GRANT_AWARD | Travere Therapeutics, Inc. | 6,500 | 0.00 USD | |
| 15 May 2025 | GRANT_AWARD | Travere Therapeutics, Inc. | 19,500 | 0.00 USD | deriv |
| 10 Apr 2025 | OTHER | Indaptus Therapeutics, Inc. | 4,750 | 0.04 USD | deriv |
| 10 Apr 2025 | OTHER | Indaptus Therapeutics, Inc. | 3,750 | 0.04 USD | deriv |
| 10 Apr 2025 | OTHER | Indaptus Therapeutics, Inc. | 813 | 0.04 USD | deriv |
| 10 Apr 2025 | OTHER | Indaptus Therapeutics, Inc. | 1,500 | 0.04 USD | deriv |
| 10 Apr 2025 | OTHER | Indaptus Therapeutics, Inc. | 1,563 | 0.04 USD | deriv |
| 10 Apr 2025 | OTHER | Indaptus Therapeutics, Inc. | 1,250 | 0.04 USD | deriv |
| 25 Nov 2024 | GRANT_AWARD | Indaptus Therapeutics, Inc. | 42,553 | 1.18 USD | |
| 25 Nov 2024 | GRANT_AWARD | Indaptus Therapeutics, Inc. | 42,553 | 1.18 USD | deriv |
| 09 Oct 2024 | GRANT_AWARD | Indaptus Therapeutics, Inc. | 75,000 | 0.00 USD | deriv |
3 purchases reported after at least 12 months of silence — most recent on 14 Sept 2021.